House E&C wordmark
Provider groups criticized draft legislation to address drug shortages from the House Energy and Commerce Committee.

Provider Groups Oppose 340B Provisions in Committee Chair’s Drug Shortage Bill

Draft legislation that would exclude some generics from 340B and focus on penny pricing recently drew criticism from provider advocates. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.